For example, in hepatocellular carcinoma, targeting ALDOA has been shown to disrupt glycolytic balance and induce energy stress due to the accumulation of fructose-1,6-bisphosphate (FBP), thereby impairing tumor cell survival [5]. Here, ALDOA is linked to neoplasm.